Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (281-290 of 390) with videos related to

Pageof 39
Sort By:
International Journal of Hematology|May 4, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 yearsMasamitsu Yanada, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
Immunology Letters|January 7, 2014
Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cellsYukie Tanaka, Rie Yamazaki, Kiriko Terasako-Saito, et al.
Clinical Transplantation|March 29, 2016
Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantationYu Akahoshi, Shun-Ichi Kimura, Hirofumi Nakano, et al.
American Journal of Hematology|May 23, 2025
Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First TransplantationKazuki Yoshimura, Hideki Nakasone, Masaharu Tamaki, et al.
Annals of Hematology|September 23, 2015
Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALLShinichi Kako, Yu Akahoshi, Naonori Harada, et al.
Bone Marrow Transplantation|May 26, 2018
Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemiaMotohiro Kato, Mio Kurata, Junya Kanda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 7, 2017
Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletionYu Akahoshi, Junya Kanda, Ayumu Ohno, et al.
Cytotherapy|July 3, 2024
Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCTShunto Kawamura, Masaharu Tamaki, Takaaki Konuma, et al.
Transplantation and Cellular Therapy|January 27, 2026
Subsequent neoplasms after umbilical cord blood transplantation in the Japanese and European populationsJunya Kanda, Fernanda Volt, Hanadi Rafii, et al.
Transplantation and Cellular Therapy|April 23, 2022
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell TherapyTomoyasu Jo, Satoshi Yoshihara, Asuka Hada, et al.
Pageof 39

Showing results (281-290 of 390) with videos related to

Sort By:
Pageof 39
International Journal of Hematology|May 4, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 yearsMasamitsu Yanada, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
Immunology Letters|January 7, 2014
Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cellsYukie Tanaka, Rie Yamazaki, Kiriko Terasako-Saito, et al.
Clinical Transplantation|March 29, 2016
Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantationYu Akahoshi, Shun-Ichi Kimura, Hirofumi Nakano, et al.
American Journal of Hematology|May 23, 2025
Impact of Conditioning Intensity on Clinical Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Relapse After First TransplantationKazuki Yoshimura, Hideki Nakasone, Masaharu Tamaki, et al.
Annals of Hematology|September 23, 2015
Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALLShinichi Kako, Yu Akahoshi, Naonori Harada, et al.
Bone Marrow Transplantation|May 26, 2018
Impact of graft-versus-host disease on relapse and survival after allogeneic stem cell transplantation for pediatric leukemiaMotohiro Kato, Mio Kurata, Junya Kanda, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 7, 2017
Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletionYu Akahoshi, Junya Kanda, Ayumu Ohno, et al.
Cytotherapy|July 3, 2024
Superiority of BM over PBSC for recipients with pre-transplant lung dysfunction in HLA-matched allogeneic HCTShunto Kawamura, Masaharu Tamaki, Takaaki Konuma, et al.
Transplantation and Cellular Therapy|January 27, 2026
Subsequent neoplasms after umbilical cord blood transplantation in the Japanese and European populationsJunya Kanda, Fernanda Volt, Hanadi Rafii, et al.
Transplantation and Cellular Therapy|April 23, 2022
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell TherapyTomoyasu Jo, Satoshi Yoshihara, Asuka Hada, et al.
Pageof 39